Meeting of the World Trade Center Health Program Scientific/Technical Advisory Committee, 71277-71279 [2024-19624]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
tkelley on LAP7H3WLY3PROD with NOTICES2
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
appropriate; (4) advise on grant,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Matters to be Considered: The agenda
will include an update on priorities
from the CDC Director, discussions on
strategic science and impact, artificial
intelligence, childhood immunization
coverage and efforts to address lagging
rates, global update, and updates from
the ACD Data and Surveillance
Workgroup and the Communications
and Public Engagement Workgroup.
Agenda items are subject to change as
priorities dictate.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written Public Comment: The docket
will be opened to receive written
comments on September 3, 2024
through October 7, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–19623 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
71277
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0064; NIOSH 248–
L]
Meeting of the World Trade Center
Health Program Scientific/Technical
Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health, Subcommittee for
Procedure Reviews; Cancellation of
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This is to notify the public
that the July 30, 2024, meeting of the
Advisory Board on Radiation and
Worker Health, Subcommittee for
Procedure Reviews is cancelled.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., National
Institute for Occupational Safety and
Health, CDC, 1090 Tusculum Avenue,
Mailstop C–24, Cincinnati, Ohio 45226,
Telephone: (513) 533–6800, Toll Free
1(800) CDC–INFO, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given of a change in the meeting
of the Advisory Board on Radiation and
Worker Health, Subcommittee for
Procedure Reviews (ABRWH, SPR). The
meeting was announced in the Federal
Register on May 17, 2024, Volume 89,
Number 97, page 43404. This meeting is
being canceled in its entirety. The
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–19622 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the World Trade
Center Health Program Scientific/
Technical Advisory Committee (STAC).
This virtual meeting is open to the
public. Time will be available for public
comment.
DATES: The meeting will be held on
September 23, 2024, from 11 a.m. to 3
p.m., EDT.
Written public comments must be
received by September 23, 2024, at
11:59 p.m., EDT. Members of the public
who wish to address the STAC during
the oral public comment session must
sign up to speak by September 16, 2024,
at the email address provided in the
Procedure for Oral Public Comment
section below.
ADDRESSES: This is a virtual meeting
conducted via Zoom. The public is
welcome to follow the proceedings via
YouTube Live at the following link:
https://youtube.com/live/7Pokfh4kcsc?
feature=share. No registration is
required. For additional information,
please visit the World Trade Center
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified
by Docket No. CDC–2024–0064; NIOSH
248–L by either of the methods listed
below. CDC does not accept comments
by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2024–0064; NIOSH 248–L.
Instructions: All submissions received
must include the Agency name and
docket number (CDC–2024–0064;
NIOSH 248–L). The docket will close on
SUMMARY:
U:\REGISTER\03SEN1.SGM
03SEN1
71278
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
September 23, 2024. All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
tkelley on LAP7H3WLY3PROD with NOTICES2
FOR FURTHER INFORMATION CONTACT:
Tania Carreón-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027. Telephone: (513)
841–4515; Email: wtc-stac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center
(WTC) Health Program, including the
WTC Health Program Scientific/
Technical Advisory Committee (STAC),
was established by title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347, as
amended by Public Law 114–113,
Public Law 116–59, Public Law 117–
328, and Public Law 118–31, adding
title XXXIII to the Public Health Service
(PHS) Act (codified at 42 U.S.C. 300mm
to 300mm–64). Title XXXIII of the PHS
Act established the WTC Health
Program within the Department of
Health and Human Services. The WTC
Health Program provides medical
monitoring and treatment benefits to
eligible firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001, or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors).
All references to the Administrator in
this document mean the Director of the
National Institute for Occupational
Safety and Health (NIOSH), within the
Centers for Disease Control and
Prevention (CDC), or his or her
designee.
Purpose: The purpose of the STAC is
to review scientific and medical
evidence and to make recommendations
to the Administrator of the WTC Health
Program regarding additional WTC
Health Program eligibility criteria,
potential additions to the List of WTCRelated Health Conditions (List), and
research regarding certain health
conditions related to the September 11,
2001, terrorist attacks. In accordance
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
with section 3312(a)(6)(G)(i)(II) of the
PHS Act, the Administrator must ask
the STAC to review and evaluate any
substantive amendment to any existing
WTC Health Program policy or
procedure used to determine whether
sufficient evidence exists to support
adding a health condition to the List of
WTC-Related Health Conditions.
The Administrator is responsible for
the administration of the STAC. CDC
and NIOSH provide funding, staffing,
and administrative support services for
the Committee. The STAC’s charter was
reissued on May 12, 2023, and will
expire on May 12, 2025.
Matters to Be Considered: The agenda
will include updates on the status of
WTC Health Program Research and the
Youth Research Cohort. It will include
a presentation on the expansion of the
WTC Health Program enrollment
eligibility for Pentagon and Shanksville
responders. In addition, there will be a
presentation about non-substantive
revisions to the existing Policy and
Procedures for Adding Non-Cancer
Health Conditions to the List of WTCRelated Health Conditions.
Background documents as well as the
agenda for this meeting are available on
the WTC Health Program website at
https://www.cdc.gov/wtc/stac_
meeting.html. Agenda items are subject
to change as priorities dictate.
Public Participation
Interested parties may participate by
submitting written views, opinions,
recommendations, and data. You may
submit comments on any topic related
to the matters to be discussed by the
Committee. Comments received,
including attachments and other
supporting materials, are part of the
public record and subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Oral Public Comment: The public is
welcome to participate, via Zoom,
during the public comment period on
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
September 23, 2024, from 1:15 p.m. to
1:45 p.m., EDT. Each commenter will be
provided up to five minutes for
comment. A limited number of time
slots are available and will be assigned
on a first-come, first-served basis.
Procedure for Oral Public Comment:
Members of the public who wish to
address the STAC during the oral public
comment session at the September 23,
2024, STAC meeting must sign up to
speak by providing their name to Ms.
Mia Wallace, Committee Management
Specialist, via email at MWallace@
cdc.gov, by September 16, 2024. Zoom
instructions and participation details
will follow.
Written Public Comment: Written
comments will also be accepted per the
instructions provided in the Addresses
section above. Written public comments
received prior to the meeting will be
part of the official record of the meeting.
The docket will close on September 23,
2024.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within
60 days after the meeting. If individuals
making a comment give their name, no
attempt will be made to redact the
name. NIOSH will take reasonable steps
to ensure that individuals making
public comments are aware that their
comments (including their names, if
provided) will appear in a transcript of
the meeting posted on a public website.
Such reasonable steps include a
statement read at the start of the meeting
stating that transcripts will be posted,
and that names of speakers will not be
redacted. If individuals in making a
statement reveal personal information
(e.g., medical information) about
themselves, that information will not
usually be redacted. The CDC Freedom
of Information Act coordinator will,
however, review such revelations in
accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third-party medical
information will be redacted.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
U:\REGISTER\03SEN1.SGM
03SEN1
Federal Register / Vol. 89, No. 170 / Tuesday, September 3, 2024 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–19624 Filed 8–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–1102]
tkelley on LAP7H3WLY3PROD with NOTICES2
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Information
Collection for Tuberculosis Data from
Panel Physicians’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice June 4, 2024
to obtain comments from the public and
affected agencies. CDC received two
comments related to the previous
notice. This notice serves to allow an
additional 30 days for public and
affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
VerDate Sep<11>2014
22:46 Aug 30, 2024
Jkt 262001
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Information Collection for
Tuberculosis Data from Panel
Physicians (OMB Control No. 0920–
1102, Exp. 12/31/2024)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration Health (DGMH), Immigrant
and Refugee Health Branch (IRHB),
requests approval for Revision to an
approved information collection. CDC
requests this data collection approval
for three years.
Respondents for this data collection
request are U.S. panel physicians. Panel
physicians are medically trained,
licensed, and experienced medical
doctors practicing overseas who are
appointed by the local U.S. Embassy or
Consulate General to perform medical
examinations for prospective
immigrants to the United States. More
than 760 panel physicians perform
overseas pre-departure medical
examinations at 333 panel sites, in
accordance with requirements, referred
to as Technical Instructions, provided
by the CDC’s DGMH, Quality
Assessment Program (QAP). The QAP is
housed in the IRHB. The role of QAP is
to assist and guide panel physicians in
the implementation of the Technical
Instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
71279
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the Technical
Instructions requirements, panel
physicians perform chest x-rays and
laboratory tests that aid in the
identification of tuberculosis infection
(Class B1 applicants) and diagnosis of
active tuberculosis disease (Class A,
inadmissible applicants). CDC uses
these classifications to report new
immigrant and refugee arrivals with a
higher risk of developing TB disease to
U.S. state and local health departments
for further follow-up. Some information
that panel physicians collect as part of
the medical exam is not reported on the
standard Department of State forms (DSforms), thereby preventing CDC from
evaluating TB trends in globally mobile
populations and monitoring program
effectiveness.
In 2007, CDC revised the Tuberculosis
Technical Instructions to include
several new requirements for
Mycobacteria tuberculosis (MTB) testing
and treatment. Important changes
included the requirements for: (1)
sputum cultures in addition to sputum
smears; (2) tuberculin skin tests or
interferon gamma release assays
(beginning in 2009) for certain children
aged 2–14 years examined in countries
where the World Health Organization
(WHO) estimated TB incidence is ≥20
per 100,000 persons; (3) drugsusceptibility testing of positive isolates;
and (4) treatment being delivered as
directly observed therapy (DOT)
throughout the entire course.
Since implementation of these new
Culture and Directly Observed Therapy
TB Technical Instructions (CDOT TB
TI), overseas TB case detection has
increased by an estimated 60% and
allowed U.S. public health programs to
save millions of dollars annually.
Overseas TB screening data (referred to
by DGMH as ‘TB Indicator data’) is
critical to support the continued
analysis of these trends and the
monitoring of TB control efforts in the
U.S. DGMH’s TB Indicator data provides
valuable epidemiologic data on globally
mobile populations and allows CDC to
monitor the effectiveness and impact of
CDC’s Technical Instructions in
diagnosing applicants with TB disease.
This data will be used to:
Æ Improve quality assurance efforts
and monitor proficiency of TB screening
programs overseas
Æ Estimate the impact of the CDOT
TB TI on the immigrant screening
program by analyzing the number of
smear negative/culture positive TB
U:\REGISTER\03SEN1.SGM
03SEN1
]]>Agencies
[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71277-71279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0064; NIOSH 248-L]
Meeting of the World Trade Center Health Program Scientific/
Technical Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the World Trade Center Health Program Scientific/
Technical Advisory Committee (STAC). This virtual meeting is open to
the public. Time will be available for public comment.
DATES: The meeting will be held on September 23, 2024, from 11 a.m. to
3 p.m., EDT.
Written public comments must be received by September 23, 2024, at
11:59 p.m., EDT. Members of the public who wish to address the STAC
during the oral public comment session must sign up to speak by
September 16, 2024, at the email address provided in the Procedure for
Oral Public Comment section below.
ADDRESSES: This is a virtual meeting conducted via Zoom. The public is
welcome to follow the proceedings via YouTube Live at the following
link: https://youtube.com/live/7Pokfh4kcsc?feature=share. No
registration is required. For additional information, please visit the
World Trade Center Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified by Docket No. CDC-2024-0064;
NIOSH 248-L by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention, 1090 Tusculum Avenue, Mailstop C-34,
Cincinnati, Ohio 45226. Attn: Docket No. CDC-2024-0064; NIOSH 248-L.
Instructions: All submissions received must include the Agency name
and docket number (CDC-2024-0064; NIOSH 248-L). The docket will close
on
[[Page 71278]]
September 23, 2024. All relevant comments, including any personal
information provided, will be posted without change to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
M.S., Designated Federal Officer, World Trade Center Health Program
Scientific/Technical Advisory Committee, National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop R-12, Atlanta, Georgia
30329-4027. Telephone: (513) 841-4515; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center (WTC) Health Program, including
the WTC Health Program Scientific/Technical Advisory Committee (STAC),
was established by title I of the James Zadroga 9/11 Health and
Compensation Act of 2010, Public Law 111-347, as amended by Public Law
114-113, Public Law 116-59, Public Law 117-328, and Public Law 118-31,
adding title XXXIII to the Public Health Service (PHS) Act (codified at
42 U.S.C. 300mm to 300mm-64). Title XXXIII of the PHS Act established
the WTC Health Program within the Department of Health and Human
Services. The WTC Health Program provides medical monitoring and
treatment benefits to eligible firefighters and related personnel, law
enforcement officers, and rescue, recovery, and cleanup workers who
responded to the September 11, 2001, terrorist attacks in New York
City, at the Pentagon, and in Shanksville, Pennsylvania (responders),
and to eligible persons who were present in the dust or dust cloud on
September 11, 2001, or who worked, resided, or attended school,
childcare, or adult daycare in the New York City disaster area
(survivors).
All references to the Administrator in this document mean the
Director of the National Institute for Occupational Safety and Health
(NIOSH), within the Centers for Disease Control and Prevention (CDC),
or his or her designee.
Purpose: The purpose of the STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the WTC Health Program regarding additional WTC Health Program
eligibility criteria, potential additions to the List of WTC-Related
Health Conditions (List), and research regarding certain health
conditions related to the September 11, 2001, terrorist attacks. In
accordance with section 3312(a)(6)(G)(i)(II) of the PHS Act, the
Administrator must ask the STAC to review and evaluate any substantive
amendment to any existing WTC Health Program policy or procedure used
to determine whether sufficient evidence exists to support adding a
health condition to the List of WTC-Related Health Conditions.
The Administrator is responsible for the administration of the
STAC. CDC and NIOSH provide funding, staffing, and administrative
support services for the Committee. The STAC's charter was reissued on
May 12, 2023, and will expire on May 12, 2025.
Matters to Be Considered: The agenda will include updates on the
status of WTC Health Program Research and the Youth Research Cohort. It
will include a presentation on the expansion of the WTC Health Program
enrollment eligibility for Pentagon and Shanksville responders. In
addition, there will be a presentation about non-substantive revisions
to the existing Policy and Procedures for Adding Non-Cancer Health
Conditions to the List of WTC-Related Health Conditions.
Background documents as well as the agenda for this meeting are
available on the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. Agenda items are subject to change as priorities
dictate.
Public Participation
Interested parties may participate by submitting written views,
opinions, recommendations, and data. You may submit comments on any
topic related to the matters to be discussed by the Committee. Comments
received, including attachments and other supporting materials, are
part of the public record and subject to public disclosure. Do not
include any information in your comment or supporting materials that
you consider confidential or inappropriate for public disclosure. If
you include your name, contact information, or other information that
identifies you in the body of your comments, that information will be
on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near-duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment period on September 23, 2024, from 1:15
p.m. to 1:45 p.m., EDT. Each commenter will be provided up to five
minutes for comment. A limited number of time slots are available and
will be assigned on a first-come, first-served basis.
Procedure for Oral Public Comment: Members of the public who wish
to address the STAC during the oral public comment session at the
September 23, 2024, STAC meeting must sign up to speak by providing
their name to Ms. Mia Wallace, Committee Management Specialist, via
email at [email protected], by September 16, 2024. Zoom instructions and
participation details will follow.
Written Public Comment: Written comments will also be accepted per
the instructions provided in the Addresses section above. Written
public comments received prior to the meeting will be part of the
official record of the meeting. The docket will close on September 23,
2024.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If individuals
making a comment give their name, no attempt will be made to redact the
name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
names, if provided) will appear in a transcript of the meeting posted
on a public website. Such reasonable steps include a statement read at
the start of the meeting stating that transcripts will be posted, and
that names of speakers will not be redacted. If individuals in making a
statement reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third-party medical information will be
redacted.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
[[Page 71279]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-19624 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P
